Patents by Inventor Samuel LUKOWSKI

Samuel LUKOWSKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250130222
    Abstract: The present invention relates to a method for identification of common patient-spanning tumor-specific T cell receptors (TCRs) and their corresponding antigens. The invention also relates to these TCR sequences, a nucleic acid encoding the TCR, and a T cell comprising the TCR and/or the encoding nucleic acid.
    Type: Application
    Filed: July 15, 2022
    Publication date: April 24, 2025
    Applicants: HS DIAGNOMICS GMBH, BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Rudolf HAMMER, Steffen HENNIG, Paul ADAM, Samuel LUKOWSKI, David WEISMANN
  • Publication number: 20240033336
    Abstract: The present invention relates to tumor antigens encoded in a 5?-upstream open reading frame (uORF) within the 5? UTR of different mRNAs. Compositions and peptides comprising such tumor antigens and a virus encoding such tumor antigens are provided. The present invention also relates to the use of such compositions, peptides and viruses in the treatment of cancer.
    Type: Application
    Filed: March 15, 2023
    Publication date: February 1, 2024
    Inventors: Elodie BELNOUE, Madiha DEROUAZI, Paul ADAM, Imgard Rita Maria HOFMANN, Ralf LEONHARDT, Samuel LUKOWSKI, Tobias NOLDEN, Francesca TRAPANI